Mostrar el registro sencillo del ítem

Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity

dc.contributor.authorBarrachina, M. N.
dc.contributor.authorIzquierdo, I.
dc.contributor.authorHermida-Nogueira, L.
dc.contributor.authorMartís Sueiro, Aurelio Manuel
dc.contributor.authorGuitián, E.
dc.contributor.authorCasanueva Freijo, Felipe 
dc.contributor.authorFarndale, R. W.
dc.contributor.authorMoroi, M.
dc.contributor.authorJung, S. M.
dc.contributor.authorPardo, M.
dc.contributor.authorGarcía, Á
dc.date.accessioned2021-09-29T12:43:08Z
dc.date.available2021-09-29T12:43:08Z
dc.date.issued2019
dc.identifier.issn2352-3409
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/31372431es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15377
dc.description.abstractThis data article is associated with the manuscript "GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: elucidating potential anti-atherothrombotic targets in obesity" [1]. The study refers to a combination of different approaches in order to identify platelet-derived biomarkers in obesity. A total of 34 obese patients and their lean-matched controls were included in the study. We carried out a proteomic and functional (aggregation assays) analysis to find alterations in platelet-derived signalling pathways. After that, biochemical and mechanistic (flow cytometry assays) approaches were done in order to confirm a hyperactivation of the GPVI-related signalling pathway.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleData on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesityes
dc.typeArtigoes
dc.authorsophosBarrachina, M. N.
dc.authorsophosIzquierdo, I.
dc.authorsophosHermida-Nogueira, L.
dc.authorsophosSueiro, A. M.
dc.authorsophosGuitián, E.
dc.authorsophosCasanueva, F. F.
dc.authorsophosFarndale, R. W.
dc.authorsophosMoroi, M.
dc.authorsophosJung, S. M.
dc.authorsophosPardo, M.
dc.authorsophosGarcía, Á
dc.identifier.doi10.1016/j.dib.2019.103784
dc.identifier.pmid31372431
dc.identifier.sophos30581
dc.issue.number23es
dc.journal.titleData in Briefes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Endocrinoloxía
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.page.initial103784es
dc.relation.publisherversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661234/pdf/main.pdf
dc.rights.accessRightsopenAccess
dc.subject.keywordCHUS
dc.subject.keywordIDIS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number23es


Ficheros en el ítem

Descargar/
Nombre:
6824-30581.pdf
Tamaño:
460.1Kb
Formato:
PDF
Descripción:
Data Brief . 2019 Feb 28;23:103784. doi: 10.1016/j.dib.2019.103784

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional